aluates Reports

$ 0.0

Automative

Antivirals - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: September 2024

Report Code: QYRE-Auto-32H6962

Global Antivirals Market Insights and Forecast to 2028

BUY CHAPTERS

Antivirals - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-32H6962

Report

September 2024

Pages:124

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Merck

Johnson & Johnson

Teva Pharmaceutical Industries

GSK

Mylan NV

Gilead Sciences

F.Hoffmann-La Roche

Bristol–Myers Squibb

AbbVie

Aurobindo Pharma

Cipla Ltd

Dr. Reddy's

Antivirals - Market Size

The global market for Antivirals was estimated to be worth US$ 44620 million in 2023 and is forecast to a readjusted size of US$ 62600 million by 2030 with a CAGR of 4.5% during the forecast period 2024-2030

Antivirals - Market

Antiviral drugs are a class of medication used specifically for treating viral infections rather than bacterial ones. Most antivirals are used for specific viral infections, while a broad-spectrum antiviral is effective against a wide range of viruses. Unlike most antibiotics, antiviral drugs do not destroy their target pathogen; instead they inhibit their development.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Antivirals, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Antivirals by region & country, by Type, and by Application.

The Antivirals market size, estimations, and forecasts are provided in terms of sales volume (K MT) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antivirals.

Market Segmentation

Scope of Antivirals - Market Report

Report Metric	Details
Report Name	Antivirals - Market
Forecasted market size in 2030	US$ 62600 million
CAGR	4.5%
Forecasted years	2024 - 2030
Segment by Type:	Generic Branded
Segment by Application	HIV Hepatitis HSV Influenza
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Merck, Johnson & Johnson, Teva Pharmaceutical Industries, GSK, Mylan, Gilead Sciences, F. Hoffmann-La Roche, Bristol-Myers-Squibb, AbbVie, Aurobindo Pharma, Cipla, Dr Reddy’s
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Antivirals manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Antivirals in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Antivirals in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Antivirals - Market size in 2030?

Ans: The Antivirals - Market size in 2030 will be US$ 62600 million.

Who are the main players in the Antivirals - Market report?

Ans: The main players in the Antivirals - Market are Merck, Johnson & Johnson, Teva Pharmaceutical Industries, GSK, Mylan, Gilead Sciences, F. Hoffmann-La Roche, Bristol-Myers-Squibb, AbbVie, Aurobindo Pharma, Cipla, Dr Reddy’s

What are the Application segmentation covered in the Antivirals - Market report?

Ans: The Applications covered in the Antivirals - Market report are HIV, Hepatitis, HSV, Influenza

What are the Type segmentation covered in the Antivirals - Market report?

Ans: The Types covered in the Antivirals - Market report are Generic, Branded

Recommended Reports

Antiviral Drugs & Treatments

Viral Vaccines & Diagnostics

Antimicrobial & Virus Treatments

1 Market Overview

1.1 Antivirals Product Introduction

1.2 Global Antivirals Market Size Forecast

1.2.1 Global Antivirals Sales Value (2019-2030)

1.2.2 Global Antivirals Sales Volume (2019-2030)

1.2.3 Global Antivirals Sales Price (2019-2030)

1.3 Antivirals Market Trends & Drivers

1.3.1 Antivirals Industry Trends

1.3.2 Antivirals Market Drivers & Opportunity

1.3.3 Antivirals Market Challenges

1.3.4 Antivirals Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Antivirals Players Revenue Ranking (2023)

2.2 Global Antivirals Revenue by Company (2019-2024)

2.3 Global Antivirals Players Sales Volume Ranking (2023)

2.4 Global Antivirals Sales Volume by Company Players (2019-2024)

2.5 Global Antivirals Average Price by Company (2019-2024)

2.6 Key Manufacturers Antivirals Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Antivirals Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Antivirals

2.9 Antivirals Market Competitive Analysis

2.9.1 Antivirals Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Antivirals Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antivirals as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Generic

3.1.2 Branded

3.2 Global Antivirals Sales Value by Type

3.2.1 Global Antivirals Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Antivirals Sales Value, by Type (2019-2030)

3.2.3 Global Antivirals Sales Value, by Type (%) (2019-2030)

3.3 Global Antivirals Sales Volume by Type

3.3.1 Global Antivirals Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Antivirals Sales Volume, by Type (2019-2030)

3.3.3 Global Antivirals Sales Volume, by Type (%) (2019-2030)

3.4 Global Antivirals Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 HIV

4.1.2 Hepatitis

4.1.3 HSV

4.1.4 Influenza

4.2 Global Antivirals Sales Value by Application

4.2.1 Global Antivirals Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Antivirals Sales Value, by Application (2019-2030)

4.2.3 Global Antivirals Sales Value, by Application (%) (2019-2030)

4.3 Global Antivirals Sales Volume by Application

4.3.1 Global Antivirals Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Antivirals Sales Volume, by Application (2019-2030)

4.3.3 Global Antivirals Sales Volume, by Application (%) (2019-2030)

4.4 Global Antivirals Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Antivirals Sales Value by Region

5.1.1 Global Antivirals Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Antivirals Sales Value by Region (2019-2024)

5.1.3 Global Antivirals Sales Value by Region (2025-2030)

5.1.4 Global Antivirals Sales Value by Region (%), (2019-2030)

5.2 Global Antivirals Sales Volume by Region

5.2.1 Global Antivirals Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Antivirals Sales Volume by Region (2019-2024)

5.2.3 Global Antivirals Sales Volume by Region (2025-2030)

5.2.4 Global Antivirals Sales Volume by Region (%), (2019-2030)

5.3 Global Antivirals Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Antivirals Sales Value, 2019-2030

5.4.2 North America Antivirals Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Antivirals Sales Value, 2019-2030

5.5.2 Europe Antivirals Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Antivirals Sales Value, 2019-2030

5.6.2 Asia Pacific Antivirals Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Antivirals Sales Value, 2019-2030

5.7.2 South America Antivirals Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Antivirals Sales Value, 2019-2030

5.8.2 Middle East & Africa Antivirals Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Antivirals Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Antivirals Sales Value

6.2.1 Key Countries/Regions Antivirals Sales Value, 2019-2030

6.2.2 Key Countries/Regions Antivirals Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Antivirals Sales Value, 2019-2030

6.3.2 United States Antivirals Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Antivirals Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Antivirals Sales Value, 2019-2030

6.4.2 Europe Antivirals Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Antivirals Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Antivirals Sales Value, 2019-2030

6.5.2 China Antivirals Sales Value by Type (%), 2023 VS 2030

6.5.3 China Antivirals Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Antivirals Sales Value, 2019-2030

6.6.2 Japan Antivirals Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Antivirals Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Antivirals Sales Value, 2019-2030

6.7.2 South Korea Antivirals Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Antivirals Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Antivirals Sales Value, 2019-2030

6.8.2 Southeast Asia Antivirals Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Antivirals Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Antivirals Sales Value, 2019-2030

6.9.2 India Antivirals Sales Value by Type (%), 2023 VS 2030

6.9.3 India Antivirals Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Merck

7.1.1 Merck Company Information

7.1.2 Merck Introduction and Business Overview

7.1.3 Merck Antivirals Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Merck Antivirals Product Offerings

7.1.5 Merck Recent Development

7.2 Johnson & Johnson

7.2.1 Johnson & Johnson Company Information

7.2.2 Johnson & Johnson Introduction and Business Overview

7.2.3 Johnson & Johnson Antivirals Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Johnson & Johnson Antivirals Product Offerings

7.2.5 Johnson & Johnson Recent Development

7.3 Teva Pharmaceutical Industries

7.3.1 Teva Pharmaceutical Industries Company Information

7.3.2 Teva Pharmaceutical Industries Introduction and Business Overview

7.3.3 Teva Pharmaceutical Industries Antivirals Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Teva Pharmaceutical Industries Antivirals Product Offerings

7.3.5 Teva Pharmaceutical Industries Recent Development

7.4 GSK

7.4.1 GSK Company Information

7.4.2 GSK Introduction and Business Overview

7.4.3 GSK Antivirals Sales, Revenue and Gross Margin (2019-2024)

7.4.4 GSK Antivirals Product Offerings

7.4.5 GSK Recent Development

7.5 Mylan

7.5.1 Mylan Company Information

7.5.2 Mylan Introduction and Business Overview

7.5.3 Mylan Antivirals Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Mylan Antivirals Product Offerings

7.5.5 Mylan Recent Development

7.6 Gilead Sciences

7.6.1 Gilead Sciences Company Information

7.6.2 Gilead Sciences Introduction and Business Overview

7.6.3 Gilead Sciences Antivirals Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Gilead Sciences Antivirals Product Offerings

7.6.5 Gilead Sciences Recent Development

7.7 F. Hoffmann-La Roche

7.7.1 F. Hoffmann-La Roche Company Information

7.7.2 F. Hoffmann-La Roche Introduction and Business Overview

7.7.3 F. Hoffmann-La Roche Antivirals Sales, Revenue and Gross Margin (2019-2024)

7.7.4 F. Hoffmann-La Roche Antivirals Product Offerings

7.7.5 F. Hoffmann-La Roche Recent Development

7.8 Bristol-Myers-Squibb

7.8.1 Bristol-Myers-Squibb Company Information

7.8.2 Bristol-Myers-Squibb Introduction and Business Overview

7.8.3 Bristol-Myers-Squibb Antivirals Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Bristol-Myers-Squibb Antivirals Product Offerings

7.8.5 Bristol-Myers-Squibb Recent Development

7.9 AbbVie

7.9.1 AbbVie Company Information

7.9.2 AbbVie Introduction and Business Overview

7.9.3 AbbVie Antivirals Sales, Revenue and Gross Margin (2019-2024)

7.9.4 AbbVie Antivirals Product Offerings

7.9.5 AbbVie Recent Development

7.10 Aurobindo Pharma

7.10.1 Aurobindo Pharma Company Information

7.10.2 Aurobindo Pharma Introduction and Business Overview

7.10.3 Aurobindo Pharma Antivirals Sales, Revenue and Gross Margin (2019-2024)

7.10.4 Aurobindo Pharma Antivirals Product Offerings

7.10.5 Aurobindo Pharma Recent Development

7.11 Cipla

7.11.1 Cipla Company Information

7.11.2 Cipla Introduction and Business Overview

7.11.3 Cipla Antivirals Sales, Revenue and Gross Margin (2019-2024)

7.11.4 Cipla Antivirals Product Offerings

7.11.5 Cipla Recent Development

7.12 Dr Reddy’s

7.12.1 Dr Reddy’s Company Information

7.12.2 Dr Reddy’s Introduction and Business Overview

7.12.3 Dr Reddy’s Antivirals Sales, Revenue and Gross Margin (2019-2024)

7.12.4 Dr Reddy’s Antivirals Product Offerings

7.12.5 Dr Reddy’s Recent Development

8 Industry Chain Analysis

8.1 Antivirals Industrial Chain

8.2 Antivirals Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Antivirals Sales Model

8.5.2 Sales Channel

8.5.3 Antivirals Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Merck

Johnson & Johnson

Teva Pharmaceutical Industries

GSK

Mylan NV

Gilead Sciences

F.Hoffmann-La Roche

Bristol–Myers Squibb

AbbVie

Aurobindo Pharma

Cipla Ltd

Dr. Reddy's

List of Tables

Table 1. Antivirals Market Trends

Table 2. Antivirals Market Drivers & Opportunity

Table 3. Antivirals Market Challenges

Table 4. Antivirals Market Restraints

Table 5. Global Antivirals Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Antivirals Revenue Market Share by Company (2019-2024)

Table 7. Global Antivirals Sales Volume by Company (2019-2024) & (K MT)

Table 8. Global Antivirals Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Antivirals Price by Company (2019-2024) & (USD/MT)

Table 10. Key Manufacturers Antivirals Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Antivirals Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Antivirals

Table 13. Global Antivirals Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antivirals as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Antivirals Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Antivirals Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Antivirals Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Antivirals Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Antivirals Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Antivirals Sales Volume by Type: 2019 VS 2023 VS 2030 (K MT)

Table 22. Global Antivirals Sales Volume by Type (2019-2024) & (K MT)

Table 23. Global Antivirals Sales Volume by Type (2025-2030) & (K MT)

Table 24. Global Antivirals Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Antivirals Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Antivirals Price by Type (2019-2024) & (USD/MT)

Table 27. Global Antivirals Price by Type (2025-2030) & (USD/MT)

Table 28. Global Antivirals Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Antivirals Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Antivirals Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Antivirals Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Antivirals Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Antivirals Sales Volume by Application: 2019 VS 2023 VS 2030 (K MT)

Table 34. Global Antivirals Sales Volume by Application (2019-2024) & (K MT)

Table 35. Global Antivirals Sales Volume by Application (2025-2030) & (K MT)

Table 36. Global Antivirals Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Antivirals Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Antivirals Price by Application (2019-2024) & (USD/MT)

Table 39. Global Antivirals Price by Application (2025-2030) & (USD/MT)

Table 40. Global Antivirals Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Antivirals Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Antivirals Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Antivirals Sales Value by Region (2019-2024) & (%)

Table 44. Global Antivirals Sales Value by Region (2025-2030) & (%)

Table 45. Global Antivirals Sales Volume by Region (K MT): 2019 VS 2023 VS 2030

Table 46. Global Antivirals Sales Volume by Region (2019-2024) & (K MT)

Table 47. Global Antivirals Sales Volume by Region (2025-2030) & (K MT)

Table 48. Global Antivirals Sales Volume by Region (2019-2024) & (%)

Table 49. Global Antivirals Sales Volume by Region (2025-2030) & (%)

Table 50. Global Antivirals Average Price by Region (2019-2024) & (USD/MT)

Table 51. Global Antivirals Average Price by Region (2025-2030) & (USD/MT)

Table 52. Key Countries/Regions Antivirals Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Antivirals Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Antivirals Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Antivirals Sales Volume, (2019-2024) & (K MT)

Table 56. Key Countries/Regions Antivirals Sales Volume, (2025-2030) & (K MT)

Table 57. Merck Company Information

Table 58. Merck Introduction and Business Overview

Table 59. Merck Antivirals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 60. Merck Antivirals Product Offerings

Table 61. Merck Recent Development

Table 62. Johnson & Johnson Company Information

Table 63. Johnson & Johnson Introduction and Business Overview

Table 64. Johnson & Johnson Antivirals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 65. Johnson & Johnson Antivirals Product Offerings

Table 66. Johnson & Johnson Recent Development

Table 67. Teva Pharmaceutical Industries Company Information

Table 68. Teva Pharmaceutical Industries Introduction and Business Overview

Table 69. Teva Pharmaceutical Industries Antivirals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 70. Teva Pharmaceutical Industries Antivirals Product Offerings

Table 71. Teva Pharmaceutical Industries Recent Development

Table 72. GSK Company Information

Table 73. GSK Introduction and Business Overview

Table 74. GSK Antivirals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 75. GSK Antivirals Product Offerings

Table 76. GSK Recent Development

Table 77. Mylan Company Information

Table 78. Mylan Introduction and Business Overview

Table 79. Mylan Antivirals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 80. Mylan Antivirals Product Offerings

Table 81. Mylan Recent Development

Table 82. Gilead Sciences Company Information

Table 83. Gilead Sciences Introduction and Business Overview

Table 84. Gilead Sciences Antivirals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 85. Gilead Sciences Antivirals Product Offerings

Table 86. Gilead Sciences Recent Development

Table 87. F. Hoffmann-La Roche Company Information

Table 88. F. Hoffmann-La Roche Introduction and Business Overview

Table 89. F. Hoffmann-La Roche Antivirals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 90. F. Hoffmann-La Roche Antivirals Product Offerings

Table 91. F. Hoffmann-La Roche Recent Development

Table 92. Bristol-Myers-Squibb Company Information

Table 93. Bristol-Myers-Squibb Introduction and Business Overview

Table 94. Bristol-Myers-Squibb Antivirals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 95. Bristol-Myers-Squibb Antivirals Product Offerings

Table 96. Bristol-Myers-Squibb Recent Development

Table 97. AbbVie Company Information

Table 98. AbbVie Introduction and Business Overview

Table 99. AbbVie Antivirals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 100. AbbVie Antivirals Product Offerings

Table 101. AbbVie Recent Development

Table 102. Aurobindo Pharma Company Information

Table 103. Aurobindo Pharma Introduction and Business Overview

Table 104. Aurobindo Pharma Antivirals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 105. Aurobindo Pharma Antivirals Product Offerings

Table 106. Aurobindo Pharma Recent Development

Table 107. Cipla Company Information

Table 108. Cipla Introduction and Business Overview

Table 109. Cipla Antivirals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 110. Cipla Antivirals Product Offerings

Table 111. Cipla Recent Development

Table 112. Dr Reddy’s Company Information

Table 113. Dr Reddy’s Introduction and Business Overview

Table 114. Dr Reddy’s Antivirals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 115. Dr Reddy’s Antivirals Product Offerings

Table 116. Dr Reddy’s Recent Development

Table 117. Key Raw Materials Lists

Table 118. Raw Materials Key Suppliers Lists

Table 119. Antivirals Downstream Customers

Table 120. Antivirals Distributors List

Table 121. Research Programs/Design for This Report

Table 122. Key Data Information from Secondary Sources

Table 123. Key Data Information from Primary Sources

List of Figures

Figure 1. Antivirals Product Picture

Figure 2. Global Antivirals Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Antivirals Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Antivirals Sales Volume (2019-2030) & (K MT)

Figure 5. Global Antivirals Sales Price (2019-2030) & (USD/MT)

Figure 6. Antivirals Report Years Considered

Figure 7. Global Antivirals Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Antivirals Players Sales Volume Ranking (2023) & (K MT)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Antivirals Revenue in 2023

Figure 10. Antivirals Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Generic Picture

Figure 12. Branded Picture

Figure 13. Global Antivirals Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Antivirals Sales Value Market Share by Type, 2023 & 2030

Figure 15. Global Antivirals Sales Volume by Type (2019 VS 2023 VS 2030) & (K MT)

Figure 16. Global Antivirals Sales Volume Market Share by Type, 2023 & 2030

Figure 17. Global Antivirals Price by Type (2019-2030) & (USD/MT)

Figure 18. Product Picture of HIV

Figure 19. Product Picture of Hepatitis

Figure 20. Product Picture of HSV

Figure 21. Product Picture of Influenza

Figure 22. Global Antivirals Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 23. Global Antivirals Sales Value Market Share by Application, 2023 & 2030

Figure 24. Global Antivirals Sales Volume by Application (2019 VS 2023 VS 2030) & (K MT)

Figure 25. Global Antivirals Sales Volume Market Share by Application, 2023 & 2030

Figure 26. Global Antivirals Price by Application (2019-2030) & (USD/MT)

Figure 27. North America Antivirals Sales Value (2019-2030) & (US$ Million)

Figure 28. North America Antivirals Sales Value by Country (%), 2023 VS 2030

Figure 29. Europe Antivirals Sales Value (2019-2030) & (US$ Million)

Figure 30. Europe Antivirals Sales Value by Country (%), 2023 VS 2030

Figure 31. Asia Pacific Antivirals Sales Value (2019-2030) & (US$ Million)

Figure 32. Asia Pacific Antivirals Sales Value by Country (%), 2023 VS 2030

Figure 33. South America Antivirals Sales Value (2019-2030) & (US$ Million)

Figure 34. South America Antivirals Sales Value by Country (%), 2023 VS 2030

Figure 35. Middle East & Africa Antivirals Sales Value (2019-2030) & (US$ Million)

Figure 36. Middle East & Africa Antivirals Sales Value by Country (%), 2023 VS 2030

Figure 37. Key Countries/Regions Antivirals Sales Value (%), (2019-2030)

Figure 38. Key Countries/Regions Antivirals Sales Volume (%), (2019-2030)

Figure 39. United States Antivirals Sales Value, (2019-2030) & (US$ Million)

Figure 40. United States Antivirals Sales Value by Type (%), 2023 VS 2030

Figure 41. United States Antivirals Sales Value by Application (%), 2023 VS 2030

Figure 42. Europe Antivirals Sales Value, (2019-2030) & (US$ Million)

Figure 43. Europe Antivirals Sales Value by Type (%), 2023 VS 2030

Figure 44. Europe Antivirals Sales Value by Application (%), 2023 VS 2030

Figure 45. China Antivirals Sales Value, (2019-2030) & (US$ Million)

Figure 46. China Antivirals Sales Value by Type (%), 2023 VS 2030

Figure 47. China Antivirals Sales Value by Application (%), 2023 VS 2030

Figure 48. Japan Antivirals Sales Value, (2019-2030) & (US$ Million)

Figure 49. Japan Antivirals Sales Value by Type (%), 2023 VS 2030

Figure 50. Japan Antivirals Sales Value by Application (%), 2023 VS 2030

Figure 51. South Korea Antivirals Sales Value, (2019-2030) & (US$ Million)

Figure 52. South Korea Antivirals Sales Value by Type (%), 2023 VS 2030

Figure 53. South Korea Antivirals Sales Value by Application (%), 2023 VS 2030

Figure 54. Southeast Asia Antivirals Sales Value, (2019-2030) & (US$ Million)

Figure 55. Southeast Asia Antivirals Sales Value by Type (%), 2023 VS 2030

Figure 56. Southeast Asia Antivirals Sales Value by Application (%), 2023 VS 2030

Figure 57. India Antivirals Sales Value, (2019-2030) & (US$ Million)

Figure 58. India Antivirals Sales Value by Type (%), 2023 VS 2030

Figure 59. India Antivirals Sales Value by Application (%), 2023 VS 2030

Figure 60. Antivirals Industrial Chain

Figure 61. Antivirals Manufacturing Cost Structure

Figure 62. Channels of Distribution (Direct Sales, and Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Antiviral Drug Packaging Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Ophthalmic Antivirals Market Research Report 2025

Global Antiviral Drugs for Influenza Market Research Report 2025

Antiviral Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Antiviral Drug Resistance Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Novel Antiviral Drugs Market

Hepatic Antiviral Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Antiviral Drugs for the Treatment of Hepatitis C HCV Market Research Report 2024

Anti Infective Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Hepatitis C Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Antiviral Antimicrobial Coatings Market Research Report 2024

Global Antiviral and Antibacterial Coating Market Research Report 2024

Influenza Antiviral Drugs Market

Drugs for Anti Infective Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

OTC Anti Infective Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Pets Antibiotic Treatment Solutions Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Antiviral Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Antiviral Traditional Chinese Medicine Market Research Report 2024

Global Anti infectives Medicine Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions